Provided by Tiger Trade Technology Pte. Ltd.

Merck

150.62
-1.9300-1.27%
Volume:4.02M
Turnover:604.46M
Market Cap:371.61B
PE:118.33
High:151.36
Open:150.73
Low:149.14
Close:152.55
52wk High:154.49
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:0.66
T/O Rate:0.16%
Dividend:3.32
Dividend Rate:2.20%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.86
PE(LYR):20.69

Loading ...

Blackrock Trims Merck Stake to 8.02% from 8.08%

Reuters
·
Jul 02

Merck terminates Phase 2 Alzheimer’s study

TIPRANKS
·
Jul 02

Press Release: Merck to Hold Second-quarter 2026 Sales and Earnings Conference Call Aug. 4

Dow Jones
·
Jul 01

Merck Schedules Second-quarter 2026 Sales and Earnings Conference Call

Reuters
·
Jul 01

Sector Update: Healthcare Stocks Decline Tuesday Afternoon

MT Newswires Live
·
Jul 01

Merck's Lung Cancer Drug Seen Boosting Sales Potential, BofA Says

MT Newswires Live
·
Jun 30

Merck is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
Jun 30

BofA Securities Adjusts Merck Price Target to $141 From $130, Maintains Buy Rating

MT Newswires Live
·
Jun 30

U.S. Stocks on the Move-aerovironment, Oklo

Reuters
·
Jun 30

Market Chatter: AbbVie, Merck Investigated by US House Committee Over Clinical Trials in China

MT Newswires Live
·
Jun 30

Broadcom Stock And Two AI Automation Picks Backed By Cash Flow

Simply Wall St.
·
Jun 30

Merck & Co Inc : Bofa Global Research Raises Price Objective to $141.00 from $130.00

THOMSON REUTERS
·
Jun 30

Analysts Have Conflicting Sentiments on These Healthcare Companies: Outlook Therapeutics (OTLK), Praxis Precision Medicines (PRAX) and Merck & Company (MRK)

TIPRANKS
·
Jun 30

Merck Down 1.2%, Abbvie Down 1%

THOMSON REUTERS
·
Jun 30

Exclusive-u.s. House Committee Investigates Abbvie, Merck China Drug Trials to Determine if They Fueled China's Military Capabilities

THOMSON REUTERS
·
Jun 30

Exclusive-u.s. Lawmaker Letters Request Documents on Hundreds of Trials over About 10 Years, Including on Data Protection Processes

THOMSON REUTERS
·
Jun 30

Scotiabank Raises Merck Price Target to $155 From $136, Sector Outperform Rating Kept

MT Newswires Live
·
Jun 30

Merck price target raised to $155 from $136 at Scotiabank

TIPRANKS
·
Jun 30

Merck Agrees With ADAP Crisis Task Force to Provide Access to HIV Treatment Idvynso

MT Newswires Live
·
Jun 29

Merck Says FDA Approves Once-daily HIV Combo Pill Idvynso

Reuters
·
Jun 29